About ShanX Medtech
ShanX Medtech is a company based in Eindhoven (Netherlands) founded in 2019. ShanX Medtech has raised $17.53 million across 3 funding rounds from investors including European Union, Borski Fund and NextGen Ventures. ShanX Medtech offers products and services including KAIROS. ShanX Medtech operates in a competitive market with competitors including Access Bio, SD Biosensor, Lumos Diagnostics, Fluxergy and Module Innovations, among others.
- Headquarter Eindhoven, Netherlands
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website shanxmedtech.com
- Social LinkedIn
- Total Equity Funding$17.53M (USD)
in 3 rounds
- InvestorsEuropean Union
& 5 more
Products & Services of ShanX Medtech
ShanX Medtech offers a comprehensive portfolio of products and services, including KAIROS.
Provides ultra-rapid testing for bacterial infections to guide antibiotic treatment
Funding Insights of ShanX Medtech
ShanX Medtech has successfully raised a total of $17.53M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.53M
- Total Rounds 3
- First Round $80,910
(Sep 2023)
- Investors Count 6
All 3 funding rounds of ShanX Medtech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $17.53M | Seed | – | Borski Fund, NextGen Ventures | – |
| Jan 2026 | – | Grant | – | – | – |
| Sep 2023 | $80,910 | Grant | – | – |
6 investors in total: 6 institutional.
Investors in ShanX Medtech
ShanX Medtech has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Borski Fund and NextGen Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | borskifund.com | - | |
- | – | nextgenventures.nl | - | |
- | – | bom.nl | - | |
- | – | invest-nl.nl | - | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
- | – | cbusinez.nl | - |
Investor details for ShanX Medtech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ShanX Medtech
1 people are tracked at ShanX Medtech (1 in leadership).
| Name | Role | Group |
|---|---|---|
Sophia E Shanko | CEO | Leadership |
Complete people profiles for ShanX Medtech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ShanX Medtech
3 dated milestones of ShanX Medtech across 7 years, from founding to its latest funding, stage changes and deals.
- Founded ShanX Medtech is founded.
- Funding First funding round of $81K.
- Funding Latest funding round, Grant,.
Competitors of ShanX Medtech
ShanX Medtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Access Bio, SD Biosensor, Lumos Diagnostics, Fluxergy and Module Innovations, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| accessbio.net | 2001 | Somerset, United States | $22M | 52 | In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases. | |
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| lumosdiagnostics.com | 2017 | Carlsbad, United States | $40M | – | Diversified diagnostic assays and readers are developed for point-of-care use. | |
| fluxergy.com | 2011 | Irvine, United States | – | 74 | Provides diagnostic devices and software for clinical and veterinary point-of-care testing. | |
| moduleinnovations.com | 2014 | Pune, India | $799,890 | – | Diagnostics strip for bacterial detection | |
| dxgenco.com | 2016 | – | – | – | Point-of-care diagnostic products for diabetes and tuberculosis are provided. | |
| alantissciencesindia.com | 2020 | Manipal, India | – | – | Molecular biology and microbiology research services are provided for diagnostics. | |
| diasurebio.com | 2022 | Seoul, South Korea | $71,475 | – | Rapid antigen tests for infectious diseases are developed. | |
| novo-dx.com | 2022 | Boca Raton, United States | $1.2M | – | Point-of-care diagnostic tests are developed for in-home and clinical use. |
Detailed competitors of ShanX Medtech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ShanX Medtech
The website of ShanX Medtech (shanxmedtech.com) receives about 4.4K visits a month.
- Monthly visits4.4K
▲ 133.7% vs previous month
Similar companies to ShanX Medtech
10 companies that operate in the same segment as ShanX Medtech (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | – | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ShanX Medtech
ShanX Medtech was founded in 2019 and raised its 1st funding round 4 years after it was founded.
ShanX Medtech is headquartered in Eindhoven, Netherlands. It is registered at Eindhoven, Noord-brabant, Netherlands.
Sophia E Shanko is the current CEO of ShanX Medtech.
ShanX Medtech is a funded company, having raised a total of $17.53M across 3 funding rounds to date. The company's 1st funding round was a Grant of $80.91K, raised on Sep 2023.
Provider of in vitro diagnostic platforms for antibiotic testing. It offers diagnostic solutions to support doctors in making informed treatment decisions for bacterial infections. The flagship product, KAIROS, is a direct from sample device that provides rapid results, enabling healthcare professionals to administer correct antibiotics promptly. It aims to enhance patient outcomes and eliminate the spread of antibiotic resistant bacteria by streamlining the diagnostic process.
ShanX Medtech's top competitors include Access Bio, SD Biosensor and Lumos Diagnostics.
ShanX Medtech offers KAIROS.
ShanX Medtech has 6 investors. Key investors include European Union, Borski Fund, NextGen Ventures, CbusineZ, and BOM.